US 6576234
Reovirus for the treatment of neoplasia
expired A61KA61K35/765A61P
Quick answer
US patent 6576234 (Reovirus for the treatment of neoplasia) held by ONCOLYTICS BIOTECH INC. expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K35/765, A61P, A61P35/00, A61P35/02